CTAP


CAS No. : 103429-32-9

103429-32-9
Price and Availability of CAS No. : 103429-32-9
Size Price Stock
1mg $200 In-stock
5mg $500 In-stock
10mg $700 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-P1335
M.Wt: 1104.30
Formula: C51H69N13O11S2
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 103429-32-9 :

CTAP is a potent, highly selective, and BBB penetrant μ opioid receptor antagonist, with an IC50 of 3.5 nM. CTAP displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP can be used for the study of L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction[1][2]. IC50 & Target:IC50: 3.5 nM (μ opioid receptor), 4500 nM (δ opioid receptor)[1] In Vivo: CTAP (0-1 mg/kg, IP, single) blocks morphine’s antinociceptive effect[1].
CTAP (10 mg/kg; IP, single) has no effect on L-DOPA-induced limb, axial, orolingual, or locomotor abnormal involuntary movements[1].
CTAP is stable in the blood and serum of rats (T1/2 > 500 min), showing that the structure of this peptide offers enzymatic resistance[2].
CTAP is extensively protein-bound to albumin in the perfusion medium (68.2%) and to proteins in rat serum (84.2%)[2].

Your information is safe with us.